Zobrazeno 1 - 10
of 1 197
pro vyhledávání: '"Recombinant human growth hormone"'
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Prader-Willi syndrome (PWS) is a rare multisystemic hereditary illness. Recombinant human growth hormone (rhGH) therapy is widely recognized as the primary treatment for PWS. This study aimed to examine how different PWS genotypes
Externí odkaz:
https://doaj.org/article/0ca12f4d223a485288857e4c2495ab33
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundEpilepsy during recombinant human growth hormone (rhGH) therapy is rare in children. The potential association between rhGH treatment and epilepsy remains unclear.MethodsWe retrospectively analyzed the clinical data of two Chinese boys who
Externí odkaz:
https://doaj.org/article/9a491071d66d47a5af0348fb8790a960
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundAcromelic dysplasia caused by FBN1 mutation includes acromicric dysplasia (AD), geleophysic dysplasia 2 (GD2), and Weill-Marchesani syndrome 2 (WMS2). All three diseases share severe short stature and brachydactyly. Besides phenotypic simil
Externí odkaz:
https://doaj.org/article/f91a5afc7b0b469fa1e2fac26f7108ae
Autor:
Octavio Rivera Romero, Hyun Wook Chae, Maria Felicia Faienza, Edoardo Vergani, Chong Kun Cheon, Raffaella Di Mase, Francesco Frasca, Hae Sang Lee, Claudia Giavoli, Jihyun Kim, Antonella Klain, Jung Eun Moon, Maria Laura Iezzi, James Yeh, Antonio Aversa, Young-Jun Rhie, Ekaterina Koledova
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionTo analyse the perspectives of healthcare professionals (HCPs) regarding the acceptance of digital health solutions for growth hormone (GH) deficiency care. This study identified factors impacting HCPs’ intent to use and recommend digit
Externí odkaz:
https://doaj.org/article/d39198b264284160b7bbac5088f8dee9
Autor:
Paula van Dommelen, Lilian Arnaud, Aria Reza Assefi, Maria Lourdes Crespo, Matias Debicki, Fulvio Michelis, Ekaterina Koledova
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionThis study in Argentina evaluated the impact of the growzen™ buddy smartphone app on adherence to recombinant human growth hormone (r-hGH) treatment.MethodsThe adherence data, invitation dates with a link to the app, app activation date
Externí odkaz:
https://doaj.org/article/566051ec8bb840748015b5b5dbac0422
Autor:
Mitchell E. Geffner, Michael B. Ranke, Michael P. Wajnrajch, for the Pfizer International Growth Database Strategic Executive Committee, Strategic Advisory Board, and International Board
Publikováno v:
Annals of Pediatric Endocrinology & Metabolism, Vol 29, Iss 1, Pp 3-11 (2024)
The Kabi International Growth Study (KIGS) was first established in 1987 and is the largest pharmaco-epidemiological study of recombinant human growth hormone (rhGH). KIGS is aimed at evaluating long-term safety and treatment outcomes in pediatric su
Externí odkaz:
https://doaj.org/article/b98fa69e6d3a4b86b1e56a2cb6b1c35f
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Recombinant human growth hormone (rhGH) therapy is beneficial for children with Prader–Willi syndrome (PWS) in improving short stature and metabolism, but the effect of early rhGH treatment on respiratory and sleep parameters fo
Externí odkaz:
https://doaj.org/article/ef4ee798618b47149170cde64ad4b678
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
BackgroundShort stature is one of the most prevalent endocrine disorders in children, and its genetic basis is a complex and actively researched subject. Currently, there is limited genetic research on exome sequencing for short stature, and more lar
Externí odkaz:
https://doaj.org/article/2febfa1a7b344408a8efdde2a3fe4946
Publikováno v:
BMC Pediatrics, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background This retrospective study explored the effect on adult height of a combination of recombinant human growth hormone (rhGH) and aromatase inhibitors (AIs), or rhGH and a gonadotropin-releasing hormone analog (GnRHa), and compared the
Externí odkaz:
https://doaj.org/article/60f8c0a5e648451295d8757f0ad37050
Tricho-rhino-phalangeal Syndrome with Growth Hormone Deficiency: a Case Report and Literature Review
Autor:
CHEN Bo, LIU Qing
Publikováno v:
Zhongguo quanke yixue, Vol 26, Iss 21, Pp 2686-2689 (2023)
Tricho-rhino-phalangeal syndrome (TRPS) is a rare autosomal dominant genetic disease, which is characterized by sparse hair, pear-shaped nose, partial cone-shaped epiphyses of the phalanges of the hand (foot) and brachydactyly. We reported a patient
Externí odkaz:
https://doaj.org/article/c40d0c335f2348e5afc5ea83473d9fd3